Annexin Pharmaceuticals (Sweden) Pattern Recognition Breakaway
| ANNX Stock | SEK 14.50 0.20 1.40% |
| Symbol |
Recognition |
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was fourteen with a total number of output elements of forty-seven. The function did not return any valid pattern recognition events for the selected time horizon. Annexin Pharmaceuticals breakaway pattern warns about a short-term trend reversal.
Annexin Pharmaceuticals Technical Analysis Modules
Most technical analysis of Annexin Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Annexin from various momentum indicators to cycle indicators. When you analyze Annexin charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Annexin Pharmaceuticals Net Worth Estimate
Annexin Pharmaceuticals is a micro-cap equity. Cycle exposure impacts valuation range. Annexin Pharmaceuticals is assessed in terms of its structural contribution to portfolio diversification and long-term stability.
Methodology
Unless otherwise specified, financial data for Annexin Pharmaceuticals AB is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Annexin (SE:ANNX) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions Valuation estimates and intrinsic-value models use inputs from public financial disclosures and may not represent market consensus.
Assumptions
Inputs are aggregated from public filings and market reference sources and public institutions such as U.S. Securities and Exchange Commission (SEC) via EDGAR. Certain values may not reflect real-time changes. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.Analyst Sources
Annexin Pharmaceuticals AB may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
Learn to be your own money manager
Tracking Annexin Pharmaceuticals inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.
Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
| All Next | Launch Module |
Annexin Pharmaceuticals pair trading
Pair trading with Annexin Pharmaceuticals can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
Annexin Pharmaceuticals Pair Trading
Annexin Pharmaceuticals AB Pair Trading Analysis
The information in the correlation table below can inform Annexin Pharmaceuticals tax-loss harvesting decisions, showing which instruments historically move in lockstep with Annexin Pharmaceuticals AB and can serve as viable temporary replacements.
Negative correlation assets provide natural hedges against Annexin Pharmaceuticals positions. When Annexin Pharmaceuticals's value declines, a negatively correlated instrument tends to rise, partially offsetting portfolio losses.
Pair evaluation and Correlation analysis for Annexin Pharmaceuticals provide hedging context. This approach is commonly reviewed within sectors and across broader groups.Additional Tools for Annexin Stock Analysis
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |